- Home
- SMTI vs TWN Comparison
SMTI vs TWN Comparison
Compare SMTI & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- TWN
- Stock Information
- Founded
- SMTI 1982
- TWN 1986
- Country
- SMTI United States
- TWN Hong Kong
- Employees
- SMTI 108
- TWN N/A
- Industry
- SMTI Medical/Dental Instruments
- TWN Trusts Except Educational Religious and Charitable
- Sector
- SMTI Health Care
- TWN Finance
- Exchange
- SMTI Nasdaq
- TWN Nasdaq
- Market Cap
- SMTI 297.2M
- TWN 278.0M
- IPO Year
- SMTI N/A
- TWN N/A
- Fundamental
- Price
- SMTI $33.60
- TWN $35.19
- Analyst Decision
- SMTI Strong Buy
- TWN
- Analyst Count
- SMTI 2
- TWN 0
- Target Price
- SMTI $47.00
- TWN N/A
- AVG Volume (30 Days)
- SMTI 22.3K
- TWN 20.1K
- Earning Date
- SMTI 05-12-2025
- TWN 01-01-0001
- Dividend Yield
- SMTI N/A
- TWN 1.10%
- EPS Growth
- SMTI N/A
- TWN N/A
- EPS
- SMTI N/A
- TWN N/A
- Revenue
- SMTI $78,056,873.00
- TWN N/A
- Revenue This Year
- SMTI $35.26
- TWN N/A
- Revenue Next Year
- SMTI $20.79
- TWN N/A
- P/E Ratio
- SMTI N/A
- TWN N/A
- Revenue Growth
- SMTI 24.66
- TWN N/A
- 52 Week Low
- SMTI $26.00
- TWN $25.22
- 52 Week High
- SMTI $39.08
- TWN $41.51
- Technical
- Relative Strength Index (RSI)
- SMTI 50.14
- TWN 38.60
- Support Level
- SMTI $30.81
- TWN $34.37
- Resistance Level
- SMTI $34.92
- TWN $35.68
- Average True Range (ATR)
- SMTI 1.34
- TWN 0.87
- MACD
- SMTI 0.24
- TWN 0.02
- Stochastic Oscillator
- SMTI 69.23
- TWN 31.70
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About TWN Taiwan Fund Inc. (The)
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.